Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

13
Number of overlapping holdings
12.7%
% of IYH's 105 holdings also in XPH
31.7%
% of XPH's 41 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IYH |
Weight in XPH |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 7.3% | 3.7% | 3.7% | |
ELI LILLY & CO | 12.2% | 3.7% | 3.7% | |
MERCK & CO. INC. | 4.2% | 3.5% | 3.5% | |
PFIZER INC | 2.6% | 3.6% | 2.6% | |
BRISTOL-MYERS SQUIBB CO | 2.2% | 3.7% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to XPH
UNITEDHEALTH GROUP INC | 8.8% | |
ELI LILLY & CO | 8.4% | |
ABBVIE INC | 6.7% | |
ABBOTT LABORATORIES | 4.2% | |
JOHNSON & JOHNSON | 3.6% | |
THERMO FISHER SCIENTIFIC INC | 3.5% | |
INTUITIVE SURGICAL INC | 3.2% | |
AMGEN INC | 3.0% | |
BOSTON SCIENTIFIC CORP | 2.7% | |
GILEAD SCIENCES INC | 2.6% |
IYH Underweight Relative to XPH
TARSUS PHARMACEUTICALS, INC. | -3.9% | |
PERRIGO CO | -3.7% | |
CORCEPT THERAPEUTICS INC | -3.7% | |
AXSOME THERAPEUTICS, INC. | -3.7% | |
ELANCO ANIMAL HEALTH, INC. | -3.6% | |
PRESTIGE BRANDS HOLDINGS INC | -3.6% | |
ORGANON & CO. | -3.5% | |
INTRA-CELLULAR THERAPIES INC | -3.5% | |
ROYALTY PHARMA PLC CLASS A | -3.3% | |
VIATRIS, INC. | -3.3% |